Subscribe

DOI:

Initial experience with transfemoral implantation of the prosthesis Edwards SAPIEN XT without previous valvuloplasty in patients with severe aortic stenosis

Garcia E., Martin P., Hernandez-Antolin R., Sandoval J., Rodas C., Almeria C., Macaya C.

Single and multicentre TAVI registries

Initial experience with transfemoral implantation of the prosthesis Edwards SAPIEN XT without previous valvuloplasty in patients with severe aortic stenosis

Aims: Balloon valvuloplasty (BV) before transcatheter aortic implantation of the prosthesis has been considered a mandatory step before valve implantation. However, BV has been associated with complications such as atrioventricular block, aortic insufficiency and stroke. We report on 10 patients with severe aortic stenosis in whom direct transfemoral implantation of the SAPIEN XT was performed.

Methods and results: From November 2011 to April 2012, 10 patients (33% of the patients treated with the Edwards SAPIEN XT during that period) were selected who met the following criteria: moderate calcification, homogeneous distribution of calcium, symmetrical opening of the valve and some degree of aortic insufficiency. The valve positioning was guided by TEE in all cases. All patients had symptomatic aortic stenosis of a native valve and were high-risk for surgery. Echocardiographic characteristics: aortic annulus diameter ranged from 17 to 24 mm (determined by TEE). Six patients had mildly calcified valves; in four patients the degree of calcification was moderate. All patients had symmetric opening of the stenotic aortic valve. Mild aortic regurgitation was present in seven patients, moderate in two and trivial in one. The native valve was crossed and the prosthetic aortic valve was properly positioned in all cases and implanted in the correct position in all cases. No patient underwent post-dilatation and only one patient had mild periprosthetic regurgitation. There were no adverse events (death, need for pacemaker, myocardial infarction or stroke). At 30 days post procedure, all patients had significant clinical improvement.

Conclusions: The direct implantation of an Edwards SAPIEN XT without prior balloon valvuloplasty in selected cases is feasible and safe. The number of patients in whom this technique is applicable and their impact on reducing complications has yet to be determined.

Volume 8 Supplement Q
Sep 30, 2012
Volume 8 Supplement Q
View full issue


Key metrics

Suggested by Cory

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00578 Mar 20, 2018
Valve-in-valve transcatheter aortic valve implantation into a novel, sutureless bioprosthesis: technical considerations
Andreas M et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV10I8A170 Dec 22, 2014
Self-expandable valve implantation within a failed balloon-expandable valve
Kornowski R et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV11I11A255 Feb 12, 2016
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report
Molina-Martin de Nicolas J et al
free
Trending articles
76.3

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
46.7

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
28.25

Clinical research

10.4244/EIJ-D-19-01006 Aug 7, 2020
Coronary collaterals and myocardial viability in patients with chronic total occlusions
Schumacher S et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
What were the echocardiographic characteristics of the patients included in the study?
What is the potential impact of the direct implantation technique on reducing complications associated with balloon valvuloplasty?
What are the limitations of the study, and what are the next steps to further evaluate the applicability and impact of the direct implantation technique?
How does the study contribute to the ongoing development and optimization of transcatheter aortic valve implantation (TAVI) procedures?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved